AI devices with FDA product code QUO — Adjunctive Heart Failure Status Indicator
Product code QUO (“Adjunctive Heart Failure Status Indicator” in openFDA) covers 3 devices on the FDA AI-enabled list, from 3 companies. Most are reviewed by the Cardiovascular panel (3). The most recent decision was CardioVision on November 21, 2025.
3AI devices
3Companies
2023First decision
2025-11-21Latest decision
Trend: devices per year
202320242025